Evidence map›Paper›PMID 25525734›Full record

ReviewAnnals of the American Thoracic Society2014

Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells.

Michael J Holtzman, Derek E Byers, Jennifer-Alexander Brett, Anand C Patel, Eugene Agapov, Xiaohua Jin, Kangyun Wu

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the American Thoracic Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Immune Modulation to Improve Survival of Viral Pneumonia in Mice.American journal of respiratory cell and molecular biology · 2020
    Article
  4. Article
  5. Escalating Mucus Inhibition to the Top of Our Priorities.American journal of respiratory cell and molecular biology · 2019
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michael J HoltzmanImmunology Group, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Derek E Byers
Jennifer-Alexander Brett
Anand C Patel
Eugene Agapov
Xiaohua Jin
Kangyun Wu
Washington University in St. Louis · US

Funding

VASCULAR CELL DIVERSITY IN PULMONARY HYPERTENSIONP01HL029594 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 1985 to 2012
$23.8M
Tissue and Cell Processing CoreU19AI070489 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2006 to 2016
$17.9M
Human MAIT celis in airway mucosal immune responses to intracellular infectionsU01AI095776 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2011 to 2015
$8.9M
Preclinical Development of an Anti-Mucus DrugUH2HL123429 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2015
$3.0M
IL-33 AND EXCESS MUCUS PRODUCTIONR01HL121791 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2017
$1.9M
INTERFERON SIGNAL ENHANCERS AS ANTIVIRAL THERAPEUTICSR01AI111605 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2017
$1.8M
Target Validation and Assay Development for Anti-Mucus TherapyP50HL107183 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2011 to 2012
$912k
NHLBI NIH HHS P01 HL029594NHLBI NIH HHS P01-HL29594NHLBI NIH HHS P50 HL107183NHLBI NIH HHS P50-HL107183NHLBI NIH HHS R01 HL121791NHLBI NIH HHS R01-HL121791NHLBI NIH HHS UH2 HL123429NIAID NIH HHS R01 AI111605NIAID NIH HHS U01 AI095776NIAID NIH HHS U01-AI095776NIAID NIH HHS U19 AI070489NIAID NIH HHS U19-AI070489
6 · The paper itself

Abstract

Respiratory infection is a common feature of the major human airway diseases, such as asthma and chronic obstructive pulmonary disease, but the precise link between acute infection and chronic lung disease is still undefined. In a mouse model of this process, parainfluenza virus infection is followed by long-term induction of IL-33 expression and release and in turn innate immune cell generation of IL-13 and consequent airway disease signified by excess mucus formation. IL-33 induction was traceable to a subset of secretoglobin-positive airway epithelial cells linked to progenitor/stem cell function. In corresponding studies of humans with chronic obstructive pulmonary disease, an increase in IL-33 production was also detected in concert with up-regulation of IL-13 and airway mucus formation. In this case, increased IL-33 production was localized to a subset of airway basal cells that maintain an endogenous capacity for increased pluripotency and ATP-regulated release of IL-33 even ex vivo. The results provide evidence of a sustainable epithelial cell population that may be activated by environmental danger signals to release IL-33 and thereby lead to IL-13-dependent disease. The progenitor nature of this IL-33-expressing ATP-responsive cell population could explain an acquired susceptibility to chronic airway disease. The findings may therefore provide a new paradigm to explain the role of viral infection and the innate immune system in chronic lung disease based on the influence of long-term epithelial progenitor cells programmed for excess IL-33 production. Further studies are needed to address the basis for this type of postviral reprogramming and the means to correct it and thereby restore airway mucosal immune function to normal.

Indexed as

Immunity, InnateUp-RegulationAcute DiseaseAnimalsEndothelial Progenitor CellsHumansInfectionsInterleukin-33InterleukinsMicePulmonary Disease, Chronic ObstructiveRespiratory MucosaRespiratory SystemIL33 protein, humanInterleukin-33Interleukinsairway epithelial cellIL-13IL-33innate immune responseprogenitor/stem cell

Identifiers

PMID25525734
PMCPMC4298973
OpenAlexW2112772695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.